HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MEN 11079

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        MEN 11079: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - MEN 11079: 1
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - MEN 11079: 1

Experts

1.	Bernabei, Pietrantonio: 1 article (12/2003)
2.	Biscardi, Monica: 1 article (12/2003)
3.	Caporale, Roberto: 1 article (12/2003)
4.	Ciolli, Stefania: 1 article (12/2003)
5.	Grossi, Alberto: 1 article (12/2003)
6.	Leoni, Franco: 1 article (12/2003)
7.	Pagliai, Gabriella: 1 article (12/2003)
8.	Santini, Valeria: 1 article (12/2003)

Related Diseases

1.

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

12/01/2003 - "The biological activity of MEN 11079, a new daunorubucin analogue with a fluorine atom in C(8) of ring A, was investigated in the human leukemic cell lines K-562 and in mononuclear cells (MNCs) of 40 patients with acute myeloid leukemia (AML) and the activity compared to two well-characterized anthracyclines, idarubicin (IDA) and doxorubicin (DOXO). "

Related Drugs and Biologics

1.	Anthracyclines
2.	Idarubicin (4 Demethoxydaunorubicin)
3.	Fluorine
4.	Doxorubicin (Adriamycin)